Stoke Therapeutics

United States

Last Updated May 8, 2025

Company Overview

Company Name

Stoke Therapeutics

Address

United States

About Stoke Therapeutics

Stoke Therapeutics is a biopharmaceutical company based in the United States that is focused on developing RNA-based therapies to address genetic diseases. The company's proprietary TANGO platform aims to restore missing proteins by increasing protein output from healthy genes, compensating for non-functioning gene copies.

Frequently Asked Questions about Stoke Therapeutics

Social Profiles

Key Decision Makers

Isabel Aznarez Co-Founder
LinkedIn
Stephanie Patriarca Senior Clinical DMPK Study Manager
LinkedIn
Amber Rawat Sr. Clinical Trial Manager
LinkedIn